Clinical trial
Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)
NCT02675218 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bone MicroArchitecture Abatacept in Rheumatoid Arthritis Patients (BMA2)
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 10, 2016
- Completion date
- June 4, 2019
- Enrollment
- 13 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.